Bartosch C

ORCID: 0000-0003-0646-7667 · 3 papers in corpus
2021
Next Generation Sequencing of Tumor and Matched Plasma Samples: Identification of Somatic Variants in ctDNA From Ovarian Cancer Patients.
Frontiers in oncology ·doi:10.3389/fonc.2021.754094

Genetic testing to detect somatic alterations is usually performed on formalin-fixed paraffin-embedded tumor samples. However, tumor molecular profiling through ctDNA analysis may be particularly interesting with the emergence of targeted t…

2017
Reproducibility of measurement of myometrial invasion in endometrial carcinoma.
Virchows Archiv : an international journal of pathology ·doi:10.1007/s00428-016-2035-5

Myometrial invasion (MI) as a percentage (%MI), categorized into <50 or ≥50 %, is an important predictor of prognosis in endometrial carcinoma. Recent studies suggest that tumor-free distance (TFD) to serosa and the absolute depth of invasi…

2016
Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium.
Oncotarget ·doi:10.18632/oncotarget.6691

Sirtuins participate in hormone imbalance, metabolism and aging, which are important processes for endometrial cancer (EC) development. Sirtuins mRNA expression (SIRT1 to 7) was determined in 76 ECs (63 Type I, 12 Type II and one mixed EC),…